{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:32:31Z","timestamp":1793521951828,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull Math Biol"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s11538-010-9553-0","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T16:56:35Z","timestamp":1276016195000},"page":"1082-1100","source":"Crossref","is-referenced-by-count":20,"title":["Strategic Treatment Interruptions During Imatinib Treatment of Chronic Myelogenous Leukemia"],"prefix":"10.1007","volume":"73","author":[{"given":"Dana","family":"Paquin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"issue":"2","key":"9553_CR1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3934\/mbe.2004.1.223","volume":"1","author":"B. M. Adams","year":"2004","unstructured":"Adams, B. M., Banks, H. T., Kwon, H.-D., & Tran, H. T. (2004). Dynamic multidrug therapies for HIV: optimal and STI control approaches. Math. Biosci. Eng., 1(2), 223\u2013241.","journal-title":"Math. Biosci. Eng."},{"key":"9553_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00001622-200403000-00002","volume":"16","author":"G. Angstreich","year":"2004","unstructured":"Angstreich, G., Smith, B., & Jones, R. (2004). Treatment options for chronic myelogenous leukemia: imatinib versus interferon versus allogeneic transplant. Curr. Opin. Oncol., 16, 95\u201399.","journal-title":"Curr. Opin. Oncol."},{"key":"9553_CR3","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.bulm.2003.11.003","volume":"66","author":"S. H. Bajaria","year":"2004","unstructured":"Bajaria, S. H., Webb, G., & Kirschner, D. E. (2004). Predicting differential responses to structured treatment interruptions during HAART. Bull. Math. Biol., 66, 1093\u20131118.","journal-title":"Bull. Math. Biol."},{"issue":"11","key":"9553_CR4","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.1182\/blood-2007-12-128397","volume":"111","author":"C. Chen","year":"2008","unstructured":"Chen, C., Maecker, H., & Lee, P. (2008). Development and dynamics of robust T-cell responses to CML. Blood, 111(11), 5342\u20135349.","journal-title":"Blood"},{"key":"9553_CR5","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/1078-0432.CCR-04-2139","volume":"11","author":"J. Cortes","year":"2005","unstructured":"Cortes, J., Talpaz, M., O\u2019Brien, S., Jones, D., Luthra, R. et al. (2005). Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate. Clin. Cancer Res., 11, 3425\u20133432.","journal-title":"Clin. Cancer Res."},{"key":"9553_CR6","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1634\/stemcells.2006-0136","volume":"24","author":"D. Dingli","year":"2006","unstructured":"Dingli, D., & Michor, F. (2006). Successful therapy must eradicate cancer stem cells. Stem Cells, 24, 2603\u20132610.","journal-title":"Stem Cells"},{"issue":"6","key":"9553_CR7","volume":"4","author":"P. Kim","year":"2008","unstructured":"Kim, P., Lee, P., & Levy, D. (2008). Dynamics and potential impact of the immune response to chronic myelogenous leukemia. PLoS Comput. Biol., 4(6), e1000095.","journal-title":"PLoS Comput. Biol."},{"key":"9553_CR8","doi-asserted-by":"crossref","first-page":"9714","DOI":"10.1073\/pnas.0501870102","volume":"102","author":"N. Komarova","year":"2005","unstructured":"Komarova, N., & Wodarz, D. (2005). Drug resistance in cancer: Principles of emergence and prevention. Proc. Natl. Acad. Sci., 102, 9714\u20139719.","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"9553_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0010041","volume":"1","author":"R. Koup","year":"2004","unstructured":"Koup, R. (2004). Reconsidering early HIV treatment and supervised treatment interruptions. PLoS Med., 1(2), e41.","journal-title":"PLoS Med."},{"key":"9553_CR10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1046\/j.1365-2141.2000.02216.x","volume":"111","author":"S. Lee","year":"2000","unstructured":"Lee, S. (2000). Chronic myelogenous leukemia. Br. J. Hematol., 111, 993\u20131009.","journal-title":"Br. J. Hematol."},{"key":"9553_CR11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJMp038130","volume":"349","author":"B. Lowenberg","year":"2003","unstructured":"Lowenberg, B. (2003). Minimal residual disease in chronic myeloid leukemia. N. Engl. J. Med., 349, 1399\u20131401.","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"9553_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/157016207780636506","volume":"5","author":"R. Maserati","year":"2007","unstructured":"Maserati, R., Foli, A., Tomasoni, L., Sighinolfi, L., Maggiolo, F., Sacchini, D., DiPietro, M., Bertelli, D., Tinelli, C., & Lori, F. (2007). Effects of structured treatment interruptions on metabolic anthropometric, immunologic, and quality of life outcomes in HIV-positive adults on HAART. Curr. HIV Res., 5(3), 337\u2013343.","journal-title":"Curr. HIV Res."},{"key":"9553_CR13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2307\/1268522","volume":"21","author":"M. D. McKay","year":"1979","unstructured":"McKay, M. D., Conover, W. J., & Beckman, R. J. (1979). A comparison of three models for selecting values of input variables in the analysis of output from a computer code. Technometrics, 21, 239\u2013245.","journal-title":"Technometrics"},{"key":"9553_CR14","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1200\/jco.2009.27.15_suppl.7084","volume":"27","author":"F. Mahon","year":"2009","unstructured":"Mahon, F., Rea, D., Guilhot, F., Legros, L., Guilhot, J., Aton, E., Dulucq, S., Reiffers, J., & Rousselot, P. (2009). Persistence of complete molecular remission in chronic myeloid leukemia after imatinib discontinuation: interim analysis of the STIM trial. J. Clin. Oncol., 27, 7084.","journal-title":"J. Clin. Oncol."},{"key":"9553_CR15","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","volume":"435","author":"F. Michor","year":"2005","unstructured":"Michor, F., Hughes, T., Iwasa, Y., Branford, S., Shah, N., Sawyers, C., & Nowak, M. (2005). Dynamics of chronic myeloid leukemia. Nature, 435, 1267\u20131270.","journal-title":"Nature"},{"key":"9553_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bcmd.2006.06.002","volume":"37","author":"R. Piazza","year":"2006","unstructured":"Piazza, R., Magistroni, V., Franceschino, A., Andreoni, F., Tornaghi, L. et al. (2006). The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with imatinib mesylate predicts for prolonged response at 6 years. Blood Cells Mol. Dis. 37, 111\u2013115.","journal-title":"Blood Cells Mol. Dis."},{"key":"9553_CR17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00109-007-0241-y","volume":"86","author":"I. Roeder","year":"2008","unstructured":"Roeder, I., & Glauche, I. (2008). Pathogenesis, treatment effects, and resistance dynamics in chronic myeloid leukemia\u2013insights from mathematical model analyses. J. Mol. Med., 86, 17\u201327.","journal-title":"J. Mol. Med."},{"key":"9553_CR18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/nm1487","volume":"12","author":"I. Roeder","year":"2006","unstructured":"Roeder, I., Horn, M., Glauche, I., Hochhaus, A., Mueller, M. et al. (2006). Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical applications. Nat. Med., 12, 1181\u20131184.","journal-title":"Nat. Med."},{"key":"9553_CR19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","volume":"109","author":"P. Rousselot","year":"2007","unstructured":"Rousselot, P., Huguet, F., Rea, D., Legros, L., Cayuela, J. M. et al. (2007). Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years. Blood, 109, 58\u201360.","journal-title":"Blood"},{"key":"9553_CR20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"C. Sawyers","year":"2000","unstructured":"Sawyers, C. (2000). Chronic myeloid leukemia. N. Engl. J. Med., 340, 1330\u20131340.","journal-title":"N. Engl. J. Med."}],"container-title":["Bulletin of Mathematical Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-010-9553-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11538-010-9553-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11538-010-9553-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T23:16:28Z","timestamp":1635462988000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11538-010-9553-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["9553"],"URL":"https:\/\/doi.org\/10.1007\/s11538-010-9553-0","relation":{},"ISSN":["0092-8240","1522-9602"],"issn-type":[{"value":"0092-8240","type":"print"},{"value":"1522-9602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,9]]}}}